FDA Drug Information Soundcast in Clinical Oncolog

FDA D.I.S.C.O. Burst Edition: FDA approval of OGSIVEO (nirogacestat) for adult patients with progressing desmoid...

Listen to a soundcast of the November 27, 2023 FDA approval of OGSIVEO (nirogacestat) for adult...

• 0
• 0
• 3 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Augtyro (repotrectinib) for locally advanced or metastatic...

FDA D.I.S.C.O. Burst Edition: FDA approval of Augtyro (repotrectinib) for locally advanced or...

• 0
• 0
• 4 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with metastatic colorectal...

FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with...

• 0
• 0
• 4 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or refractory...

FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or...

• 0
• 0
• 5 meses

FDA D.I.S.C.O. Burst Edition: FDA approvals of Talvey (talquetamab-tgvs) for relapsed or refractory multiple myeloma,...

FDA D.I.S.C.O. Burst Edition: FDA approvals of Talvey (talquetamab-tgvs) for relapsed or...

• 0
• 0
• 7 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Lynparza (olaparib), with abiraterone and prednisone, for BRCA-mutated...

Listen to a soundcast of the May 31, 2023, FDA approval of Lynparza (olaparib), with abiraterone...

• 0
• 0
• 9 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large...

Listen to a soundcast of the May 19, 2023, FDA approval of Epkinly (epcoritamab-bysp) for...

• 0
• 0
• 10 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse...

Listen to a soundcast of the April 19, 2023, FDA approval of Polivy (polatuzumab vedotin-piiq)...

• 0
• 0
• 10 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Omisirge (omidubicel-onlv) to reduce time to neutrophil recovery and...

Listen to a soundcast of the April 17, 2023, FDA approval of Omisirge (omidubicel-onlv) to reduce...

• 0
• 0
• 11 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) for...

Listen to a soundcast of the April 19, 2023, FDA approval of Padcev (enfortumab vedotin-ejfv)...

• 0
• 0
• 11 meses

FDA D.I.S.C.O. Burst Edition: FDA approval of Zynyz (retifanlimab-dlwr) for metastatic or recurrent locally advanced...

Lsten to a soundcast of the March 22, 2023 FDA approval of Zynyz (retifanlimab-dlwr) for...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients...

Listen to a soundcast of the March 16, 2023, FDA approval of Tafinlar (dabrafenib) for pediatric...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approval of Verzenio (abemaciclib) with endocrine therapy for patients with...

Listen to a soundcast of the March 3, 2023, FDA approval of Verzenio (abemaciclib) with endocrine...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approval of Jemperli (dostarlimab-gxly) for dMMR endometrial cancer

Listen to a soundcast of the February 9, 2023, FDA approval of Jemperli (dostarlimab-gxly) for...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approval of Trodelvy (sacituzumab govitecan-hziy) for HR-positive breast cancer

Listen to a soundcast of the February 3, 2023, FDA approval of Trodelvy (sacituzumab...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) as adjuvant treatment for non-small cell lung...

Listen to a soundcast of the January 26, 2023, FDA approval of Keytruda (pembrolizumab) as...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approvals of Jaypirca (pirtobrutinib) for relapsed or refractory mantle cell...

Listen to a soundcast of the January 27, 2023, FDA approvals of Jaypirca (pirtobrutinib) for...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approvals of Tukysa (tucatinib) with trastuzumab for colorectal cancer and Brukinsa...

Listen to a soundcast of the January 19, 2023, FDA approvals of Tukysa (tucatinib) with...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approvals of Tecentriq (atezolizumab) for unresectable or metastatic alveolar soft...

Listen to a soundcast of the December 9 and 12, 2022, FDA approvals of Tecentriq (atezolizumab)...

• 0
• 0
• 1 año

FDA D.I.S.C.O. Burst Edition: FDA approval of Adstiladrin (nadofaragene firadenovec-vncg) for patients with high-risk...

Listen to a soundcast of the December 16, 2022, FDA approval of Adstiladrin (nadofaragene...

• 0
• 0
• 1 año